XIN [Xinyuan Real Estate] 6-K: XINYUAN REAL ESTATE CO., LTD. ACQUIRES NEW YORK

[XINYUAN REAL ESTATE CO., LTD. ACQUIRES NEW YORK CITY DEVELOPMENT SITE BEIJING, September 28, 2012 th The property offers a total site area of approximately 92,000 square feet (8,547 square meters), and already has approximately US$8 million of permitting, zoning and foundation construction completed. Located in the trendy Williamsburg area, the site will accommodate approximately 506,000 square feet (47,194 square] []

SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Sinovac Reports Unaudited Second Quarter 2012 Financial Results - Conference call scheduled for Wednesday, August 15, 2012 at 8:00 AM EDT - BEIJING, Aug. 15, 2012 /PRNewswire-Asia/ — Sinovac Biotech Ltd. (the company) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited second quarter financial results for the period ended June 30, 2012. Sinovac is] []

By | 2016-03-24T00:55:12+00:00 September 28th, 2012|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 6-K: Sinovac Reports Unaudited Second Quarter 2012 Financial Results

[Sinovac Reports Unaudited Second Quarter 2012 Financial Results - Conference call scheduled for Wednesday, August 15, 2012 at 8:00 AM EDT - BEIJING, Aug. 15, 2012 /PRNewswire-Asia/ — Sinovac Biotech Ltd. (the company) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited second quarter financial results for the period ended June 30, 2012. Sinovac is] []

By | 2016-03-24T00:57:32+00:00 September 28th, 2012|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments

IMOS [CHIPMOS TECHNOLOGIES BERMUDA] 6-K: (Original Filing)

[Operating and Financial Review and Prospects This operating and financial review and prospects (“FRP”) discusses and analyzes the financial condition and results of ChipMOS TECHNOLOGIES (Bermuda) LTD, (also referred to as “we”, “our”, “ChipMOS” or “the Company”) for the six month period ended June 30, 2012. This should be read in conjunction with our unaudited condensed interim consolidated financial statements]

By | 2016-03-25T13:26:58+00:00 September 28th, 2012|Categories: Chinese Stocks, IMOS, SEC Original|Tags: , , , , , |0 Comments

IMOS [CHIPMOS TECHNOLOGIES BERMUDA] 6-K: Operating and Financial Review and Prospects This operating

[Operating and Financial Review and Prospects This operating and financial review and prospects (“FRP”) discusses and analyzes the financial condition and results of ChipMOS TECHNOLOGIES (Bermuda) LTD, (also referred to as “we”, “our”, “ChipMOS” or “the Company”) for the six month period ended June 30, 2012. This should be read in conjunction with our unaudited condensed interim consolidated financial statements]

By | 2016-03-25T13:28:13+00:00 September 28th, 2012|Categories: Chinese Stocks, IMOS, Webplus ver|Tags: , , , , , |0 Comments

JASO [JA Solar] 6-K: (Original Filing)

[JA Solar Commences Large-Volume Module Shipments From Bids Totaling 70MW With China Guangdong Nuclear Solar Energy SHANGHAI, China, Sept. 26, 2012 (GLOBE NEWSWIRE) — JA Solar Holdings Co., Ltd. (Nasdaq:JASO) (“JA Solar” or the “Company”), one of the world’s largest manufacturers of high-performance solar power products, today announced that it has commenced solar module shipments from successful bids totaling 70MW]

By | 2016-03-08T11:17:30+00:00 September 28th, 2012|Categories: Chinese Stocks, JASO, SEC Original|Tags: , , , , , |0 Comments

TPI [TIANYIN PHARMACEUTICAL] 10-K: (Original Filing)

[FORM 10-K x FOR THE FISCAL YEAR ENDED JUNE 30, 2012 o FOR THE TRANSITION PERIOD FROM TO TIANYIN PHARMACEUTICAL CO., INC. Delaware (State or other jurisdiction of incorporation) (I.R.S. Employer Identification or Organization No.) 23rd Floor, UnionsunYangkuo Plaza No.2, Block 3, Renmin Road South, Chengdu, 610041 P. R. China 0086-028-86154737 and principal place of business) Securities registered under Section] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER I, Guoqing Jiang certify that: 1. I have reviewed this annual report on Form 10-K of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [CERTIFICATION OF CHIEF FINANCIAL OFFICER I, James J. Tong, certify that: 1. I have reviewed this annual report on Form 10-K of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2)T he information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Chief Executive Officer, Chief Accounting Officer] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. James J. Tong Chief Financial Officer]

By | 2016-03-27T19:15:30+00:00 September 28th, 2012|Categories: Chinese Stocks, SEC Original, TPI|Tags: , , , , , |0 Comments

JASO [JA Solar] 6-K: (Original Filing)

[JA Solar Commences Large-Volume Module Shipments From Bids Totaling 90MW With China Power Investment SHANGHAI, China, Sept. 26, 2012 (GLOBE NEWSWIRE) — JA Solar Holdings Co., Ltd., (Nasdaq:JASO) (“JA Solar” or the “Company”), one of the world’s largest manufacturers of high-performance solar power products, today announced that it has commenced solar module shipments from successful bids totaling 90MW with China]

By | 2016-03-08T11:21:19+00:00 September 28th, 2012|Categories: Chinese Stocks, JASO, SEC Original|Tags: , , , , , |0 Comments
Skip to toolbar